Results 41 to 50 of about 11,910 (159)

Literature Review: Role of Neurosurgery in Leptomeningeal Carcinomatosis

open access: yesBrazilian Neurosurgery, 2023
Introduction Leptomeningeal carcinomatosis results from metastatic neoplastic cells that reach the leptomeninges through the cerebrospinal fluid. The presentation of the disease is variable, making prognosis challenging.
Thaís Mitie Ogasawara   +9 more
doaj   +1 more source

Boron‐embedded multifunctional nanoplatform toward potential combined boron neutron capture therapy and immunomodulation in glioma

open access: yesSmart Molecules, EarlyView.
A brain‐targeting multifunctional nanoplatform (DM&Ce6@COF‐Ang) was engineered by employing boron‐enriched APTES‐COF‐1 as both the therapeutic boron agent and the nanocarrier co‐delivery of DMXAA and Ce6. This nanoplatform achieved synergistic tumor‐specific boron delivery, real‐time pharmacokinetic monitoring, and immunomodulation.
Yiming Liu   +13 more
wiley   +1 more source

Leptomeningeal carcinomatosis, an emerging disease in internal medicine departments with a generally poor prognosis: two case reports

open access: yesItalian Journal of Medicine
As a result of improved diagnostic methods and higher cancer patient survival rates, leptomeningeal carcinomatosis is being found in internal medicine departments more frequently.
Filomena Pietrantonio   +9 more
doaj   +1 more source

Lethal disseminated dysembryoplastic neuroepithelial tumor following West Nile virus: Report of a very unusual combination

open access: yesRadiology Case Reports, 2018
Dysembryoplastic neuroepithelial tumors (DNETs) are typically benign World Health Organization (WHO) grade I tumors of the cortical or deep gray matter with a favorable prognosis.
Amy Farkas, MD   +4 more
doaj   +1 more source

Spinal Cord Sarcoidosis Treated With Infliximab

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Isolated spinal cord lesion could be misinterpreted as a demyelinating disease. The diagnosis of sarcoidosis should be in the differential when other indices for a demyelinating disorder are absent. An inadequate response to intravenous steroid therapy should not rule out spinal sarcoidosis as this report confirms the response to intravenous ...
Hussein Moussa   +4 more
wiley   +1 more source

A case report of prostate cancer with leptomeningeal metastasis

open access: yesCancer Reports, 2022
Background Prostate cancer is the most prevalent cancer in men. However, leptomeningeal involvement by prostate carcinoma is a rare event. Case Here, we report a 69‐year‐old patient with castration‐resistant metastatic prostate cancer who presented with ...
Mansoureh Dehghani   +6 more
doaj   +1 more source

Efficacy and Safety of Intraventricular Thiotepa in Combination With Methotrexate for Leptomeningeal Metastasis From Breast Cancer (NJMU‐BC04): A Single‐Arm Phase II Study

open access: yesMedComm, Volume 7, Issue 9, September 2026.
Leptomeningeal metastasis (LM), an uncommon yet highly fatal condition, involves malignant tumor infiltration of the meninges resulting in progressive neurological deterioration and severe quality‐of‐life impairment. LM remains largely refractory to treatment and lacks standardized treatment consensus, with a low intracranial objective response rate ...
Wenbin Zhou   +10 more
wiley   +1 more source

Intrathecal Chemotherapy Through Ommaya Reservoir in Leptomeningeal Metastasis From Cervical Cancer: A Rare Case Report and Literature Review

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 52, Issue 9, September 2026.
ABSTRACT Leptomeningeal metastasis (LM) is a rare complication of cervical cancer associated with a poor prognosis. We report a 61‐year‐old woman with stage IVB cervical squamous cell carcinoma who developed acute headache and diplopia during systemic chemotherapy.
Chery Ahn   +7 more
wiley   +1 more source

Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature

open access: yesCase Reports in Oncological Medicine, 2013
We report the case of a 65-year-old woman, diagnosed with a breast cancer human epidermal growth factor receptor (HER2) previously negative, who developed leptomeningeal carcinomatosis and was treated with intrathecal (IT) trastuzumab (TST).
Cristina Dumitrescu, Dominique Lossignol
doaj   +1 more source

Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program

open access: yesTherapeutic Advances in Medical Oncology, 2021
Introduction: We report on the results of the German early access program (EAP) with the third-generation ALK- and ROS1-inhibitor lorlatinib. Patients and Methods: Patients with documented treatment failure of all approved ALK/ROS1-specific therapies or ...
Nikolaj Frost   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy